Outcomes and toxicity from a prospective study of moderately hypofractionated radiation therapy for prostate cancer.

scientific article

Outcomes and toxicity from a prospective study of moderately hypofractionated radiation therapy for prostate cancer. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.ADRO.2017.12.006
P8608Fatcat IDrelease_34rey6tymncepbbrpk6xlur6lu
P932PMC publication ID6000067
P698PubMed publication ID29904741

P2093author name stringDaniel Krauss
Hong Ye
Alvaro Martinez
Di Yan
Wei Gang Wang
Gary Gustafson
Michael Ghilezan
P2860cites workRandomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09Q33710935
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus ConferenceQ34541651
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate CancerQ35979481
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trialQ36333179
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trialQ37128114
Randomized trial of hypofractionated external-beam radiotherapy for prostate cancerQ37249348
Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapyQ39220458
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trialQ39928038
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trialQ41472454
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancerQ43202742
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trialQ44375182
Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy.Q44498790
Image-guided radiotherapy for prostate cancer with cone beam CT: dosimetric effects of imaging frequency and PTV margin.Q53561115
Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts.Q53620237
Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy.Q54034626
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trialQ57539336
Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate CancerQ59650976
Fractionation and protraction for radiotherapy of prostate carcinomaQ77227878
Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissueQ77451468
Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trialQ87505183
Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trialQ87741968
P433issue2
P921main subjectadaptive radiation therapyQ180507
P304page(s)163-169
P577publication date2017-12-29
P1433published inAdvances in radiation oncologyQ27727236
P1476titleOutcomes and toxicity from a prospective study of moderately hypofractionated radiation therapy for prostate cancer.
P478volume3

Reverse relations

Q90018871Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative settingcites workP2860

Search more.